The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection

R Borrow, P Alarcón, J Carlos, DA Caugant… - Expert review of …, 2017 - Taylor & Francis
ABSTRACT Introduction: The 2015 Global Meningococcal Initiative (GMI) meeting discussed
the global importance of meningococcal disease (MD) and its continually changing …

The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic …

R Acevedo, X Bai, R Borrow, DA Caugant… - Expert review of …, 2019 - Taylor & Francis
ABSTRACT Introduction: The 2018 Global Meningococcal Initiative (GMI) meeting focused
on evolving invasive meningococcal disease (IMD) epidemiology, surveillance, and …

[HTML][HTML] High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine

LA McNamara - MMWR. Morbidity and mortality weekly report, 2017 - cdc.gov
Eculizumab (Soliris, Alexion Pharmaceuticals), a terminal complement inhibitor, is
associated with a 1,000-fold to 2,000-fold increased incidence of meningococcal disease …

Bacterial meningitis epidemiology in five countries in the meningitis belt of sub-Saharan Africa, 2015–2017

HM Soeters, AO Diallo, BW Bicaba… - The Journal of …, 2019 - academic.oup.com
Abstract Background The MenAfriNet Consortium supports strategic implementation of case-
based meningitis surveillance in key high-risk countries of the African meningitis belt …

Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease

MK Taha, F Martinon-Torres, R Köllges… - Expert review of …, 2022 - Taylor & Francis
Introduction Social deprivation is associated with poorer healthcare access. Vaccination is
among the most effective public health interventions and achieving equity in vaccination …

Meningococcal carriage evaluation in response to a serogroup B meningococcal disease outbreak and mass vaccination campaign at a college—Rhode Island, 2015 …

HM Soeters, M Whaley… - Clinical Infectious …, 2017 - academic.oup.com
Background. Serogroup B meningococcal disease caused 7 US university outbreaks during
2013–2016. Neisseria meningitidis can be transmitted via asymptomatic nasopharyngeal …

[HTML][HTML] Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal Initiative

R Borrow, DA Caugant, M Ceyhan, H Christensen… - Journal of Infection, 2017 - Elsevier
Summary The Global Meningococcal Initiative (GMI) has recently considered current issues
in Middle Eastern and African countries, and produced two recommendations:(i) that …

Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data

F Sidikou, M Zaneidou, I Alkassoum… - The Lancet Infectious …, 2016 - thelancet.com
Summary Background To combat Neisseria meningitidis serogroup A epidemics in the
meningitis belt of sub-Saharan Africa, a meningococcal serogroup A conjugate vaccine …

Meningococcal carriage following a vaccination campaign with MenB-4C and MenB-FHbp in response to a university serogroup B meningococcal disease outbreak …

LA McNamara, JD Thomas, J MacNeil… - The Journal of …, 2017 - academic.oup.com
Background Limited data exist on the impact of the serogroup B meningococcal (MenB)
vaccines MenB-FHbp and MenB-4C on meningococcal carriage and herd protection. We …

Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges

MM Mustapha, LH Harrison - Human Vaccines & …, 2018 - Taylor & Francis
Africa historically has had the highest incidence of meningococcal disease with high
endemic rates and periodic epidemics. The meningitis belt, a region of sub-Saharan Africa …